The Kentucky Viral Hepatitis Treatment Study
Key facts
- Where
- Hazard, United StatesSee the site
- Phase
- Phase 4
Where in United States
- ARH Medical MallHazard, United StatesNo longer taking part
Trial details
- Who runs it
- Jennifer Havens
- Trial code
- NCT03949764
- Record updated
- 20 October 2026
- Original description
The overarching goal of the Kentucky Viral Hepatitis Treatment Project (KeY Treat) is to increase hepatitis C virus (HCV) treatment access and delivery in a rural Appalachian community, which is in the midst of the opioid/hepatitis C (HCV) syndemic. KeY Treat is a clinical research study seeking to determine whether removing barriers (cost, insurance, specialist, abstinence) associated with accessing direct-acting antivirals (DAAs) for the treatment of HCV will impact health in Perry County, Kentucky.Read full original descriptionShow less
Increasing Access to Hepatitis C Treatment in Opioid Endemic Rural Areas: The Kentucky Viral Hepatitis Treatment (KeY Treat) Study
The overarching goal of the Kentucky Viral Hepatitis Treatment Project (KeY Treat) is to increase hepatitis C virus (HCV) treatment access and delivery in a rural Appalachian community, which is in the midst of the opioid/hepatitis C (HCV) syndemic. KeY Treat is a clinical research study seeking to determine whether removing barriers (cost, insurance, specialist, abstinence) associated with accessing direct-acting antivirals (DAAs) for the treatment of HCV will impact health in Perry County, Kentucky.
Inclusion: RNA positive for HCV; Perry County residency (verified via ID card showing local address, lease, utility bill, etc.); 18 years of age or older.
Exclusion: Individuals under 18 years of age (study drugs not FDA-approved for those <18); Individuals who are unable to provide consent (to be determined by local study staff in conjunction with our psychiatrist, Dr. Lofwall, a Co-I on the study); Pregnant women (unable to participate during duration of pregnancy, but encouraged to return following delivery).